Interview with Anthony Ch. Sunarjo, President, GPFarmasi
Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the…
Address: WISMA NUGRA SANTANA 5TH floor Jl. Jend Sudirman Kav. 7-8 Jakarta 10220, Indonesia
Tel: +62 21 5702500
Web: http://www.sunthisepuri.com/
Sunthi Sepuri is the pharmaceutical division of Nugra Santana Group a Indonesian business engaged in diverse business activities such as Hotels, Ship building, Oil drilling, Engineering, Trading and a lot more.In 1988 Sunthi Sepuri was incorporated to manufacture and market a range of ethical pharmaceuticals. In 1997 the company closed an agreement with Mepha from Switzerland to import and marketing their product in Indonesia, giving Sunthi Sepuri the necessary impetus to grow rapidly over the next five years. With a GMP manufacturing facility, important investments on quality control and R&D, Sunthi Sepuri enjoys today a great acceptance and recognition of the Medical Profession.
Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the…
How challenging is it being for you to adapt to the Indonesian business mindset. My adaptation to Indonesia has been relatively smooth thanks to my past experience in different Asian…
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry? Indonesia differs some what from other Asian countries, starting from…
IDS Distribution is part of an Asian, globe spanning Distribution Company. How does being part of a large, regionally specialized player help IDS Distribution in Indonesia? The company’s regional presence…
Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here
